(Q41754324)

8 October 2017

1 reference

title

Human immunodeficiency virus (HIV) in America, 1981 to 1997: epidemiologic and therapeutic considerations (English)

1 reference

8 October 2017

Reiter GS

1

1 reference

8 October 2017

publication date

1 April 1998

1 reference

8 October 2017

number of pages

6

1 reference

Seminars in Ultrasound, CT and MRI

inferred from page(s)

published in

1 reference

8 October 2017

volume

19

1 reference

8 October 2017

issue

2

1 reference

8 October 2017

page(s)

122-127

1 reference

Survival from early, intermediate, and late stages of HIV infection

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2171%2898%2990054-3

7 January 2021

KAPOSI'S SARCOMA IN HOMOSEXUAL MEN—A REPORT OF EIGHT CASES

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2171%2898%2990054-3

7 January 2021

Kaposi sarcoma among homosexual men in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2171%2898%2990054-3

7 January 2021

Gay compromise syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2171%2898%2990054-3

7 January 2021

Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2171%2898%2990054-3

7 January 2021

Severe Acquired Immunodeficiency in Male Homosexuals, Manifested by Chronic Perianal Ulcerative Herpes Simplex Lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2171%2898%2990054-3

7 January 2021

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2171%2898%2990054-3

7 January 2021

Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2171%2898%2990054-3

7 January 2021

Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2171%2898%2990054-3

7 January 2021

A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2171%2898%2990054-3

7 January 2021

Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2171%2898%2990054-3

7 January 2021

Mechanisms of Immunosuppression in Cytomegaloviral Mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2171%2898%2990054-3

7 January 2021

Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2171%2898%2990054-3

7 January 2021

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2171%2898%2990054-3

7 January 2021

Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2171%2898%2990054-3

7 January 2021

Seroprevalence rates of human immunodeficiency virus infection at sentinel hospitals in the United States. The Sentinel Hospital Surveillance Group

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2171%2898%2990054-3

7 January 2021

HIV infection among patients in U.S. acute care hospitals. Strategies for the counseling and testing of the hospital patients. The Hospital HIV Surveillance Group

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2171%2898%2990054-3

7 January 2021

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2171%2898%2990054-3

7 January 2021

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2171%2898%2990054-3

7 January 2021

Survival of zidovudine-treated patients with AIDS compared with that of contemporary untreated patients. Italian Zidovudine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2171%2898%2990054-3

7 January 2021

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2171%2898%2990054-3

7 January 2021

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2171%2898%2990054-3

7 January 2021

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2171%2898%2990054-3

7 January 2021

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2171%2898%2990054-3

7 January 2021

10.1016/S0887-2171(98)90054-3

Identifiers

DOI

1 reference

8 October 2017

1 reference